Epigenetic protein families: a new frontier for drug discovery
The DOI matches its Crossref record; 192 of the 194 references it cites were found in a registry or an index.
Abstract
Epigenetic regulation of gene expression is a dynamic and reversible process that establishes normal cellular phenotypes but also contributes to human diseases. At the molecular level, epigenetic regulation involves hierarchical covalent modification of DNA and the proteins that package DNA, such as histones. Here, we review the key protein families that mediate epigenetic signalling through the acetylation and methylation of histones, including histone deacetylases, protein methyltransferases, lysine demethylases, bromodomain-containing proteins and proteins that bind to methylated histones. These protein families are emerging as druggable classes of enzymes and druggable classes of protein-protein interaction domains. In this article, we discuss the known links with disease, basic molecular mechanisms of action and recent progress in the pharmacological modulation of each class of proteins.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“They have also been demonstrated to possess greater isoform selectivity profiles, targeting specifically only the class I subgroup of HDACs (6-10, 26, 38, 39).”
From Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability (2013) · cites this paper as [7]
In the citing paper
“The benzamides face a more difficult path to the observed binding mode, with two plausible binding trajectories. The ligand could enter via an acetyl release and disposal channel (7, 24, 33, 42) or via the hydrophobic tube, settling into a rearranged foot pocket before forming the zinc complex, which locks the inhibitor in place.”
From Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability (2013) · cites this paper as [7]
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Chromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
Regulation of chromatin by histone modifications
Bannister, A. J., & Kouzarides, T. (2011) · Cell Research · doi:10.1038/cr.2011.22 · Cited by 6,012
Jones, P. A., & Baylin, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.01.029 · Cited by 4,515
Selective inhibition of BET bromodomains
Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T., Felletar, I., et al. (2010) · Nature · doi:10.1038/nature09504 · Cited by 4,262
Histone demethylation mediated by the nuclear amine oxidase homolog LSD1
Shi, Y., Lan, F., Matson, C., Mulligan, P., Whetstine, J. R., Cole, P. A., Casero, R. A., & Shi, Y. (2004) · Cell · doi:10.1016/j.cell.2004.12.012 · Cited by 4,051
Lysine acetylation targets protein complexes and co-regulates major cellular functions
Choudhary, C., Kumar, C., Gnad, F., Nielsen, M. L., Rehman, M., Walther, T. C., Olsen, J. V., & Mann, M. (2009) · Science · doi:10.1126/science.1175371 · Cited by 4,040
The landscape of somatic copy-number alteration across human cancers
Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J. S., Dobson, J., Urashima, M., et al. (2010) · Nature · doi:10.1038/nature08822 · Cited by 4,017
SMART, a simple modular architecture research tool: Identification of signaling domains
Schultz, J., Milpetz, F., Bork, P., & Ponting, C. P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.5857 · Cited by 3,599
Histone deacetylases (HDACs): characterization of the classical HDAC family
RUIJTER, A. J. M. D., GENNIP, A. H. V., CARON, H. N., KEMP, S., & KUILENBURG, A. B. P. V. (2003) · Biochemical Journal · doi:10.1042/bj20021321 · Cited by 3,114
Mapping and analysis of chromatin state dynamics in nine human cell types
Ernst, J., Kheradpour, P., Mikkelsen, T. S., Shoresh, N., Ward, L. D., Epstein, C. B., Zhang, X., Wang, L., Issner, R., Coyne, M., et al. (2011) · Nature · doi:10.1038/nature09906 · Cited by 2,898
Epigenetic modifications and human disease
Portela, A., & Esteller, M. (2010) · Nature Biotechnology · doi:10.1038/nbt.1685 · Cited by 2,836 · cited 5×
“BT1(1) SFM BT2(1) L3M BTL(1) L3MBTL3(1) L3MBTL4(1) L3MBTL4(3) SFMBT1(4) SFM BT2( 4) L3M BTL( 3) L3 MB TL 3(3 ) L3 MB TL 2(4 ) M BT D 1( 4) L3 M BT L( 2) L3M BTL4(2) L3M BTL3(2) SC M H 1(2) SCM L2(2) L3MBTL2(3) MBTD1(3) SFMBT1(3) SFMBT 2(3) MBTs 390 | MAY 2012 | VOLUME 11 www.nature.com/reviews/drugdisc © 2012 Macmilla…”
InfluentialBET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Delmore, J. E., Issa, G. C., Lemieux, M. E., Rahl, P. B., Shi, J., Jacobs, H. M., Kastritis, E., Gilpatrick, T., Paranal, R. M., Qi, J., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.017 · Cited by 2,813
hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase
Vaziri, H., Dessain, S. K., Eaton, E. N., Imai, S.-I., Frye, R. A., Pandita, T. K., Guarente, L., & Weinberg, R. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00527-x · Cited by 2,659
ACETYLATION AND METHYLATION OF HISTONES AND THEIR POSSIBLE ROLE IN THE REGULATION OF RNA SYNTHESIS
Allfrey, V. G., Faulkner, R., & Mirsky, A. E. (1964) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.51.5.786 · Cited by 2,639
Epigenetic Transgenerational Actions of Endocrine Disruptors and Male Fertility
Anway, M. D., Cupp, A. S., Uzumcu, M., & Skinner, M. K. (2005) · Science · doi:10.1126/science.1108190 · Cited by 2,563
HDAC6 is a microtubule-associated deacetylase
Hubbert, C., Guardiola, A., Shao, R., Kawaguchi, Y., Ito, A., Nixon, A., Yoshida, M., Wang, X.-F., & Yao, T.-P. (2002) · Nature · doi:10.1038/417455a · Cited by 2,403
Histone demethylation by a family of JmjC domain-containing proteins
Tsukada, Y.-I., Fang, J., Erdjument-Bromage, H., Warren, M. E., Borchers, C. H., Tempst, P., & Zhang, Y. (2006) · Nature · doi:10.1038/nature04433 · Cited by 2,163
Mammalian Sirtuins: Biological Insights and Disease Relevance
Haigis, M. C., & Sinclair, D. A. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092250 · Cited by 2,085
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Zuber, J., Shi, J., Wang, E., Rappaport, A. R., Herrmann, H., Sison, E. A., Magoon, D., Qi, J., Blatt, K., Wunderlich, M., et al. (2011) · Nature · doi:10.1038/nature10334 · Cited by 1,870
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R., & Pavletich, N. P. (1999) · Nature · doi:10.1038/43710 · Cited by 1,714
Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes
Milne, J. C., Lambert, P. D., Schenk, S., Carney, D. P., Smith, J. J., Gagne, D. J., Jin, L., Boss, O., Perni, R. B., Vu, C. B., et al. (2007) · Nature · doi:10.1038/nature06261 · Cited by 1,707
Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family
Filippakopoulos, P., Picaud, S., Mangos, M., Keates, T., Lambert, J.-P., Barsyte-Lovejoy, D., Felletar, I., Volkmer, R., Müller, S., Pawson, T., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.013 · Cited by 1,694
Self-citationFunctions of Site-Specific Histone Acetylation and Deacetylation
Shahbazian, M. D., & Grunstein, M. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.052705.162114 · Cited by 1,635
Kuzmichev, A., Nishioka, K., Erdjument-Bromage, H., Tempst, P., & Reinberg, D. (2002) · Genes & Development · doi:10.1101/gad.1035902 · Cited by 1,596
Reflecting on 25 years with MYC
Meyer, N., & Penn, L. Z. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2231 · Cited by 1,575
Suppression of inflammation by a synthetic histone mimic
Nicodeme, E., Jeffrey, K. L., Schaefer, U., Beinke, S., Dewell, S., Chung, C.-W., Chandwani, R., Marazzi, I., Wilson, P., Coste, H., et al. (2010) · Nature · doi:10.1038/nature09589 · Cited by 1,563
Self-citationInhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
Dawson, M. A., Prinjha, R. K., Dittmann, A., Giotopoulos, G., Bantscheff, M., Chan, W.-I., Robson, S. C., Chung, C.-W., Hopf, C., Savitski, M. M., et al. (2011) · Nature · doi:10.1038/nature10509 · Cited by 1,503
Self-citationSirt5 Is a NAD-Dependent Protein Lysine Demalonylase and Desuccinylase
Du, J., Zhou, Y., Su, X., Yu, J. J., Khan, S., Jiang, H., Kim, J., Woo, J., Kim, J. H., Choi, B. H., et al. (2011) · Science · doi:10.1126/science.1207861 · Cited by 1,429
Taverna, S. D., Li, H., Ruthenburg, A. J., Allis, C. D., & Patel, D. J. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1338 · Cited by 1,418
Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2
Huangfu, D., Osafune, K., Maehr, R., Guo, W., Eijkelenboom, A., Chen, S., Muhlestein, W., & Melton, D. A. (2008) · Nature Biotechnology · doi:10.1038/nbt.1502 · Cited by 1,341
Epigenetics and the biological definition of gene×environment interactions
Meaney, M. J. (2010) · Child Development · doi:10.1111/j.1467-8624.2009.01381.x · Cited by 1,239 · cited 8×
“DAC10-1(1) HAC10-5 HD10-2(1) H D AC (6)(1) H D A C 6(2) D A C 9 H D A C 5 HD AC 4 HD AC 7 HD AC 2 HD AC1 HDAC3 HAC8 HAC11 SIRT7 SIRT6 -2 SIR T6 -1 SI RT 64”
InfluentialMarks, P. A., & Breslow, R. (2007) · Nature Biotechnology · doi:10.1038/nbt1272 · Cited by 1,196
Transcription factors as targets for cancer therapy
Darnell, J. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc906 · Cited by 1,194
Histone acetylation and an epigenetic code
Turner, B. M. (2000) · BioEssays · doi:10.1002/1521-1878(200009)22:9<836::aid-bies9>3.0.co;2-x · Cited by 1,182
HDAC6 Regulates Hsp90 Acetylation and Chaperone-Dependent Activation of Glucocorticoid Receptor
Kovacs, J. J., Murphy, P. J. M., Gaillard, S., Zhao, X., Wu, J.-T., Nicchitta, C. V., Yoshida, M., Toft, D. O., Pratt, W. B., & Yao, T.-P. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.04.021 · Cited by 1,153
Cellular Memory and the Histone Code
Turner, B. M. (2002) · Cell · doi:10.1016/s0092-8674(02)01080-2 · Cited by 1,142
SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin
Michishita, E., McCord, R. A., Berber, E., Kioi, M., Padilla-Nash, H., Damian, M., Cheung, P., Kusumoto, R., Kawahara, T. L. A., Barrett, J. C., et al. (2008) · Nature · doi:10.1038/nature06736 · Cited by 1,111
Covalent histone modifications — miswritten, misinterpreted and mis-erased in human cancers
Chi, P., Allis, C. D., & Wang, G. G. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2876 · Cited by 1,099
Multivalent engagement of chromatin modifications by linked binding modules
Ruthenburg, A. J., Li, H., Patel, D. J., & David Allis, C. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2298 · Cited by 1,013
Bouwman, P., Aly, A., Escandell, J. M., Pieterse, M., Bartkova, J., van der Gulden, H., Hiddingh, S., Thanasoula, M., Kulkarni, A., Yang, Q., et al. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1831 · Cited by 1,001
Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor
Daigle, S. R., Olhava, E. J., Therkelsen, C. A., Majer, C. R., Sneeringer, C. J., Song, J., Johnston, L. D., Scott, M. P., Smith, J. J., Xiao, Y., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.06.009 · Cited by 923
Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin.
Vaquero, A., Scher, M., Lee, D., Erdjument-Bromage, H., Tempst, P., & Reinberg, D. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.08.031 · Cited by 916
SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1
Pacholec, M., Bleasdale, J. E., Chrunyk, B., Cunningham, D., Flynn, D., Garofalo, R. S., Griffith, D., Griffor, M., Loulakis, P., Pabst, B., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.088682 · Cited by 915
Reversal of H3K9me2 by a Small-Molecule Inhibitor for the G9a Histone Methyltransferase
Kubicek, S., O'Sullivan, R. J., August, E. M., Hickey, E. R., Zhang, Q., Teodoro, M. L., Rea, S., Mechtler, K., Kowalski, J. A., Homon, C. A., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.01.017 · Cited by 859
Roles of the EZH2 histone methyltransferase in cancer epigenetics
Simon, J. A., & Lange, C. A. (2008) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2008.07.010 · Cited by 855
Structure and Function of a Human TAF II 250 Double Bromodomain Module
Jacobson, R. H., Ladurner, A. G., King, D. S., & Tjian, R. (2000) · Science · doi:10.1126/science.288.5470.1422 · Cited by 843
hDOT1L Links Histone Methylation to Leukemogenesis
Okada, Y., Feng, Q., Lin, Y., Jiang, Q., Li, Y., Coffield, V. M., Su, L., Xu, G., & Zhang, Y. (2005) · Cell · doi:10.1016/j.cell.2005.02.020 · Cited by 804
Epigenetic modifications as therapeutic targets
Kelly, T. K., De Carvalho, D. D., & Jones, P. A. (2010) · Nature Biotechnology · doi:10.1038/nbt.1678 · Cited by 793 · cited 15×
“DAC10-1(1) HAC10-5 HD10-2(1) H D AC (6)(1) H D A C 6(2) D A C 9 H D A C 5 HD AC 4 HD AC 7 HD AC 2 HD AC1 HDAC3 HAC8 HAC11 SIRT7 SIRT6 -2 SIR T6 -1 SI RT 64”
BackgroundInfluentialDemethylation of H3K27 Regulates Polycomb Recruitment and H2A Ubiquitination
Lee, M. G., Villa, R., Trojer, P., Norman, J., Yan, K.-P., Reinberg, D., Di Croce, L., & Shiekhattar, R. (2007) · Science · doi:10.1126/science.1149042 · Cited by 771
Sauve, A. A., Wolberger, C., Schramm, V. L., & Boeke, J. D. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133500 · Cited by 763
Chemical phylogenetics of histone deacetylases
Bradner, J. E., West, N., Grachan, M. L., Greenberg, E. F., Haggarty, S. J., Warnow, T., & Mazitschek, R. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.313 · Cited by 720
Hsieh, J., Nakashima, K., Kuwabara, T., Mejia, E., & Gage, F. H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407643101 · Cited by 719
The Genetic Landscape of the Childhood Cancer Medulloblastoma
Parsons, D. W., Li, M., Zhang, X., Jones, S., Leary, R. J., Lin, J. C.-H., Boca, S. M., Carter, H., Samayoa, J., Bettegowda, C., et al. (2011) · Science · doi:10.1126/science.1198056 · Cited by 717
CBP/p300-mediated acetylation of histone H3 on lysine 56
Das, C., Lucia, M. S., Hansen, K. C., & Tyler, J. K. (2009) · Nature · doi:10.1038/nature07861 · Cited by 697
A Combined Chemical and Genetic Approach for the Generation of Induced Pluripotent Stem Cells
Shi, Y., Tae Do, J., Desponts, C., Hahm, H. S., Schöler, H. R., & Ding, S. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.05.011 · Cited by 671
Bowers, E. M., Yan, G., Mukherjee, C., Orry, A., Wang, L., Holbert, M. A., Crump, N. T., Hazzalin, C. A., Liszczak, G., Yuan, H., et al. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.03.006 · Cited by 666
SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis
Vaquero, A., Scher, M. B., Lee, D. H., Sutton, A., Cheng, H.-L., Alt, F. W., Serrano, L., Sternglanz, R., & Reinberg, D. (2006) · Genes & Development · doi:10.1101/gad.1412706 · Cited by 665
Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes
Bantscheff, M., Hopf, C., Savitski, M. M., Dittmann, A., Grandi, P., Michon, A.-M., Schlegl, J., Abraham, Y., Becher, I., Bergamini, G., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1759 · Cited by 659
Antidepressant Actions of Histone Deacetylase Inhibitors
Covington, H. E., Maze, I., LaPlant, Q. C., Vialou, V. F., Ohnishi, Y. N., Berton, O., Fass, D. M., Renthal, W., Rush, A. J., Wu, E. Y., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.1758-09.2009 · Cited by 624
Butler, L. M., Agus, D. B., Scher, H. I., Higgins, B., Rose, A., Cordon‐Cardo, C., Thaler, H. T., Rifkind, R. A., Marks, P. A., & Richon, V. M. (2000) · PubMed · Cited by 615
Yap, D. B., Chu, J., Berg, T., Schapira, M., Cheng, S.-W. G., Moradian, A., Morin, R. D., Mungall, A. J., Meissner, B., Boyle, M., et al. (2011) · Blood · doi:10.1182/blood-2010-11-321208 · Cited by 606
Self-citationUnraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases
Lahm, A., Paolini, C., Pallaoro, M., Nardi, M. C., Jones, P., Neddermann, P., Sambucini, S., Bottomley, M. J., Lo Surdo, P., Carfı́, A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706487104 · Cited by 566
Endocrine Disruptor Vinclozolin Induced Epigenetic Transgenerational Adult-Onset Disease
Anway, M. D., Leathers, C., & Skinner, M. K. (2006) · Endocrinology · doi:10.1210/en.2006-0640 · Cited by 555
Histone deacetylases as regulators of inflammation and immunity
Shakespear, M. R., Halili, M. A., Irvine, K. M., Fairlie, D. P., & Sweet, M. J. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.04.001 · Cited by 546
Brasacchio, D., Okabe, J., Tikellis, C., Balcerczyk, A., George, P., Baker, E. K., Calkin, A. C., Brownlee, M., Cooper, M. E., & El-Osta, A. (2009) · Diabetes · doi:10.2337/db08-1666 · Cited by 534
Mihaylova, M. M., Vasquez, D. S., Ravnskjaer, K., Denechaud, P.-D., Yu, R. T., Alvarez, J. G., Downes, M., Evans, R. M., Montminy, M., & Shaw, R. J. (2011) · Cell · doi:10.1016/j.cell.2011.03.043 · Cited by 533
A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells
Vedadi, M., Barsyte-Lovejoy, D., Liu, F., Rival-Gervier, S., Allali-Hassani, A., Labrie, V., Wigle, T. J., DiMaggio, P. A., Wasney, G. A., Siarheyeva, A., et al. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.599 · Cited by 527
Self-citationIdentification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9
Greiner, D., Bonaldi, T., Eskeland, R., Roemer, E., & Imhof, A. (2005) · Nature Chemical Biology · doi:10.1038/nchembio721 · Cited by 521
Di Lorenzo, A., & Bedford, M. T. (2011) · FEBS Letters · doi:10.1016/j.febslet.2010.11.010 · Cited by 509
Epigenetic regulation of the alternatively activated macrophage phenotype
Ishii, M., Wen, H., Corsa, C. A. S., Liu, T., Coelho, A. L., Allen, R. M., Carson, W. F., Cavassani, K. A., Li, X., Lukacs, N. W., et al. (2009) · Blood · doi:10.1182/blood-2009-04-217620 · Cited by 496
Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are mutually exclusive
Guccione, E., Bassi, C., Casadio, F., Martinato, F., Cesaroni, M., Schuchlautz, H., Lüscher, B., & Amati, B. (2007) · Nature · doi:10.1038/nature06166 · Cited by 491
Solomon, J. M., Pasupuleti, R., Xu, L., McDonagh, T., Curtis, R., DiStefano, P. S., & Huber, L. J. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.1.28-38.2006 · Cited by 486
Protein methyltransferases as a target class for drug discovery
Copeland, R. A., Solomon, M. E., & Richon, V. M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2974 · Cited by 460
The structural basis of protein acetylation by the p300/CBP transcriptional coactivator
Liu, X., Wang, L., Zhao, K., Thompson, P. R., Hwang, Y., Marmorstein, R., & Cole, P. A. (2008) · Nature · doi:10.1038/nature06546 · Cited by 448
Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger
Wang, G. G., Song, J., Wang, Z., Dormann, H. L., Casadio, F., Li, H., Luo, J.-L., Patel, D. J., & Allis, C. D. (2009) · Nature · doi:10.1038/nature08036 · Cited by 438
Jmjd3 contributes to the control of gene expression in LPS-activated macrophages
De Santa, F., Narang, V., Yap, Z. H., Tusi, B. K., Burgold, T., Austenaa, L., Bucci, G., Caganova, M., Notarbartolo, S., Casola, S., et al. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.271 · Cited by 421
SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity
Yoshizaki, T., Schenk, S., Imamura, T., Babendure, J. L., Sonoda, N., Bae, E. J., Oh, D. Y., Lu, M., Milne, J. C., Westphal, C., et al. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00417.2009 · Cited by 419
Borowiak, M., Maehr, R., Chen, S., Chen, A. E., Tang, W., Fox, J. L., Schreiber, S. L., & Melton, D. A. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.01.014 · Cited by 417
Northcott, P. A., Nakahara, Y., Wu, X., Feuk, L., Ellison, D. W., Croul, S., Mack, S., Kongkham, P. N., Peacock, J., Dubuc, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.336 · Cited by 412
Grant, S., Easley, C., & Kirkpatrick, P. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2227 · Cited by 412
Mood Stabilizer Valproate Promotes ERK Pathway-Dependent Cortical Neuronal Growth and Neurogenesis
Hao, Y., Creson, T., Zhang, L., Li, P., Du, F., Yuan, P., Gould, T. D., Manji, H. K., & Chen, G. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5747-03.2004 · Cited by 404
Histone deacetylase 8 in neuroblastoma tumorigenesis
Oehme, I., Deubzer, H. E., Wegener, D., Pickert, D., Linke, J.-P., Hero, B., Kopp-Schneider, A., Westermann, F., Ulrich, S. M., von Deimling, A., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0684 · Cited by 398
Lau, O. D., Kundu, T. K., Soccio, R. E., Ait-Si-Ali, S., Khalil, E. M., Vassilev, A., Wolffe, A. P., Nakatani, Y., Roeder, R. G., & Cole, P. A. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80452-9 · Cited by 394
Signaling Network Model of Chromatin
Schreiber, S. L., & Bernstein, B. E. (2002) · Cell · doi:10.1016/s0092-8674(02)01196-0 · Cited by 393
The bromodomain: a conserved sequence found in human,Drosophila and yeast proteins
Haynes, S. R., Dollard, C., Winston, F., Beck, S., Trowsdale, J., & Dawid, I. B. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.10.2603 · Cited by 387
Heterochromatin Formation in Mammalian Cells
Nielsen, A. L., Oulad-Abdelghani, M., Ortiz, J. A., Remboutsika, E., Chambon, P., & Losson, R. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00218-0 · Cited by 383
Epigenetic modifications in pluripotent and differentiated cells
Meissner, A. (2010) · Nature Biotechnology · doi:10.1038/nbt.1684 · Cited by 372
Clinical Studies of Histone Deacetylase Inhibitors
Prince, H. M., Bishton, M. J., & Harrison, S. J. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2785 · Cited by 356
Arginine methylation at histone H3R2 controls deposition of H3K4 trimethylation
Kirmizis, A., Santos-Rosa, H., Penkett, C. J., Singer, M. A., Vermeulen, M., Mann, M., Bähler, J., Green, R. D., & Kouzarides, T. (2007) · Nature · doi:10.1038/nature06160 · Cited by 354
Identification of Novel Isoform-Selective Inhibitors within Class I Histone Deacetylases
Hu, E., Dul, E., Sung, C.-M., Chen, Z., Kirkpatrick, R., Zhang, G.-F., Johanson, K., Liu, R., Lago, A., Hofmann, G., et al. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.055541 · Cited by 347
Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response
Gorrini, C., Squatrito, M., Luise, C., Syed, N., Perna, D., Wark, L., Martinato, F., Sardella, D., Verrecchia, A., Bennett, S., et al. (2007) · Nature · doi:10.1038/nature06055 · Cited by 343
L3MBTL1, a Histone-Methylation-Dependent Chromatin Lock
Trojer, P., Li, G., Sims, R. J., Vaquero, A., Kalakonda, N., Boccuni, P., Lee, D., Erdjument-Bromage, H., Tempst, P., Nimer, S. D., et al. (2007) · Cell · doi:10.1016/j.cell.2007.03.048 · Cited by 342
Small Molecule Regulators of Protein Arginine Methyltransferases
Cheng, D., Yadav, N., King, R. W., Swanson, M. S., Weinstein, E. J., & Bedford, M. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401853200 · Cited by 339
Discovery and Characterization of Small Molecule Inhibitors of the BET Family Bromodomains
Chung, C.-W., Coste, H., White, J. H., Mirguet, O., Wilde, J., Gosmini, R. L., Delves, C., Magny, S. M., Woodward, R., Hughes, S. A., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200108t · Cited by 334
Self-citationFournel, M., Bonfils, C., Hou, Y., Yan, P. T., Trachy-Bourget, M.-C., Kalita, A., Liu, J., Lu, A.-H., Zhou, N. Z., Robert, M.-F., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2026 · Cited by 332
Control of Cognition and Adaptive Behavior by the GLP/G9a Epigenetic Suppressor Complex
Schaefer, A., Sampath, S. C., Intrator, A., Min, A., Gertler, T. S., Surmeier, D. J., Tarakhovsky, A., & Greengard, P. (2009) · Neuron · doi:10.1016/j.neuron.2009.11.019 · Cited by 317
Histone acetyl transferases as emerging drug targets
Dekker, F. J., & Haisma, H. J. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.06.008 · Cited by 315
Plumb, J. A., Finn, P. W., Williams, R. J., Bandara, M. J., Romero, M., Watkins, C. J., Thangue, N. B. L., & Brown, R. E. (2003) · PubMed · Cited by 312
Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294
Chang, Y., Zhang, X., Horton, J. R., Upadhyay, A. K., Spannhoff, A., Liu, J., Snyder, J. P., Bedford, M. T., & Cheng, X. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1560 · Cited by 308
trans-2-Phenylcyclopropylamine Is a Mechanism-Based Inactivator of the Histone Demethylase LSD1
Schmidt, D. M. Z., & McCafferty, D. G. (2007) · Biochemistry · doi:10.1021/bi0618621 · Cited by 307
Williams, S. R., Aldred, M. A., Der Kaloustian, V. M., Halal, F., Gowans, G., McLeod, D. R., Zondag, S., Toriello, H. V., Magenis, R. E., & Elsea, S. H. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.07.011 · Cited by 302
Velichutina, I., Shaknovich, R., Geng, H., Johnson, N. A., Gascoyne, R. D., Melnick, A. M., & Elemento, O. (2010) · Blood · doi:10.1182/blood-2010-04-280149 · Cited by 299
Binda, C., Valente, S., Romanenghi, M., Pilotto, S., Cirilli, R., Karytinos, A., Ciossani, G., Botrugno, O. A., Forneris, F., Tardugno, M., et al. (2010) · Journal of the American Chemical Society · doi:10.1021/ja101557k · Cited by 284
The clinical development of histone deacetylase inhibitors as targeted anticancer drugs
Marks, P. A. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2010.510514 · Cited by 281
Lin, H., Hu, C., Chan, H., Liew, Y., Huang, H., Lepescheux, L., Bastianelli, E., Baron, R., Rawadi, G., & Clément‐Lacroix, P. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707165 · Cited by 272
Abnormal histone modification patterns in lupus CD4+ T cells.
Hu, N., Qiu, X., Luo, Y., Yuan, J., Li, Y., Lei, W., Zhang, G., Zhou, Y., Su, Y., & Lu, Q. (2008) · PubMed · Cited by 271
Histone Deacetylase 6 and Heat Shock Protein 90 Control the Functions of Foxp3 + T-Regulatory Cells
de Zoeten, E. F., Wang, L., Butler, K., Beier, U. H., Akimova, T., Sai, H., Bradner, J. E., Mazitschek, R., Kozikowski, A. P., Matthias, P., et al. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05155-11 · Cited by 258
Schuetz, A., Min, J., Allali-Hassani, A., Schapira, M., Shuen, M., Loppnau, P., Mazitschek, R., Kwiatkowski, N. P., Lewis, T. A., Maglathin, R. L., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707362200 · Cited by 257
Self-citationKleefstra, T., van Zelst-Stams, W. A., Nillesen, W. M., Cormier-Daire, V, Houge, G., Foulds, N., van Dooren, M., Willemsen, M. H., Pfundt, R., Turner, A., et al. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.062950 · Cited by 252
Inhibitor Scaffolds for 2-Oxoglutarate-Dependent Histone Lysine Demethylases
Rose, N. R., Ng, S. S., Mecinović, J., Liénard, B. M. R., Bello, S. H., Sun, Z., McDonough, M. A., Oppermann, U., & Schofield, C. J. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800936s · Cited by 250
Santer, F. R., Höschele, P. P. S., Oh, S. J., Erb, H. H. H., Bouchal, J., Cavarretta, I. T., Parson, W., Meyers, D. J., Cole, P. A., & Culig, Z. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0182 · Cited by 235
King, O. N. F., Li, X. S., Sakurai, M., Kawamura, A., Rose, N. R., Ng, S. S., Quinn, A. M., Rai, G., Mott, B. T., Beswick, P., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015535 · Cited by 223
SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy
Riessland, M., Ackermann, B., Förster, A., Jakubik, M., Hauke, J., Garbes, L., Fritzsche, I., Mende, Y., Blumcke, I., Hahnen, E., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq023 · Cited by 220
Epigenetic regulation of the neural transcriptome: the meaning of the marks
Meaney, M. J., & Ferguson-Smith, A. C. (2010) · Nature Neuroscience · doi:10.1038/nn1110-1313 · Cited by 216
Lai, C.-J., Bao, R., Tao, X., Wang, J., Atoyan, R., Qu, H., Wang, D.-G., Yin, L., Samson, M., Forrester, J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3360 · Cited by 212
Kleine-Kohlbrecher, D., Christensen, J., Vandamme, J., Abarrategui, I., Bak, M., Tommerup, N., Shi, X., Gozani, O., Rappsilber, J., Salcini, A. E., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.03.002 · Cited by 212
Grabiec, A. M., Korchynskyi, O., Tak, P. P., & Reedquist, K. A. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2011.154211 · Cited by 211
Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis
Ciavatta, D. J., Yang, J., Preston, G. A., Badhwar, A. K., Xiao, H., Hewins, P., Nester, C. M., Pendergraft, W. F., Magnuson, T. R., Jennette, J. C., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40034 · Cited by 210
Protective Role of SIRT1 in Diabetic Vascular Dysfunction
Orimo, M., Minamino, T., Miyauchi, H., Tateno, K., Okada, S., Moriya, J., & Komuro, I. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.185694 · Cited by 209
Liu, F., Chen, X., Allali-Hassani, A., Quinn, A. M., Wigle, T. J., Wasney, G. A., Dong, A., Senisterra, G., Chau, I., Siarheyeva, A., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100478y · Cited by 205
Self-citationStructural Basis of Substrate Methylation and Inhibition of SMYD2
Ferguson, A. D., Larsen, N. A., Howard, T., Pollard, H., Green, I., Grande, C., Cheung, T., Garcia-Arenas, R., Cowen, S., Wu, J., et al. (2011) · Structure · doi:10.1016/j.str.2011.06.011 · Cited by 203
Chen, X., El Gazzar, M., Yoza, B. K., & McCall, C. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.000950 · Cited by 201
Mocetinostat for relapsed classical Hodgkin's lymphoma: an open-label, single-arm, phase 2 trial
Younes, A., Oki, Y., Bociek, R. G., Kuruvilla, J., Fanale, M., Neelapu, S., Copeland, A., Buglio, D., Galal, A., Besterman, J., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70265-0 · Cited by 196
Resveratrol regulates human adipocyte number and function in a Sirt1-dependent manner
Fischer-Posovszky, P., Kukulus, V., Tews, D., Unterkircher, T., Debatin, K.-M., Fulda, S., & Wabitsch, M. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28435 · Cited by 195
Design and evaluation of ‘Linkerless’ hydroxamic acids as selective HDAC8 inhibitors
KrennHrubec, K., Marshall, B. L., Hedglin, M., Verdin, E., & Ulrich, S. M. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.02.064 · Cited by 192
Chemogenetic Analysis of Human Protein Methyltransferases
Richon, V. M., Johnston, D., Sneeringer, C. J., Jin, L., Majer, C. R., Elliston, K., Jerva, L. F., Scott, M. P., & Copeland, R. A. (2011) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2011.01135.x · Cited by 188
Wang, J., Weaver, I. C. G., Gauthier-Fisher, A., Wang, H., He, L., Yeomans, J., Wondisford, F., Kaplan, D. R., & Miller, F. D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2009.10.023 · Cited by 186
p300-mediated Acetylation of Histone H3 Lysine 56 Functions in DNA Damage Response in Mammals
Vempati, R. K., Jayani, R. S., Notani, D., Sengupta, A., Galande, S., & Haldar, D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.149393 · Cited by 175
Mimasu, S., Umezawa, N., Sato, S., Higuchi, T., Umehara, T., & Yokoyama, S. (2010) · Biochemistry · doi:10.1021/bi100299r · Cited by 175
Bamborough, P., Diallo, H., Goodacre, J. D., Gordon, L., Lewis, A., Seal, J. T., Wilson, D. M., Woodrow, M. D., & Chung, C.-W. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201283q · Cited by 175
Caron, C., Lestrat, C., Marsal, S., Escoffier, E., Curtet, S., Virolle, V, Barbry, P., Debernardi, A., Brambilla, C., Brambilla, E., et al. (2010) · Oncogene · doi:10.1038/onc.2010.259 · Cited by 173
The Emerging Therapeutic Potential of Histone Methyltransferase and Demethylase Inhibitors
Spannhoff, A., Hauser, A., Heinke, R., Sippl, W., & Jung, M. (2009) · ChemMedChem · doi:10.1002/cmdc.200900301 · Cited by 171
Kalashnikova, E. V., Revenko, A. S., Gemo, A. T., Andrews, N. P., Tepper, C. G., Zou, J. X., Cardiff, R. D., Borowsky, A. D., & Chen, H.-W. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1199 · Cited by 168
Romidepsin: a novel histone deacetylase inhibitor for cancer
Bertino, E. M., & Otterson, G. A. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.594437 · Cited by 166
Chiurazzi, P., Schwartz, C. E., Gecz, J., & Neri, G. (2008) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201994 · Cited by 165
CREB Binding Protein Is Required for Both Short-Term and Long-Term Memory Formation
Chen, G., Zou, X., Watanabe, H., van Deursen, J. M., & Shen, J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.2378-10.2010 · Cited by 165
Vetterli, L., Brun, T., Giovannoni, L., Bosco, D., & Maechler, P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.176842 · Cited by 165
Taberlay, P. C., & Jones, P. A. (2011) · Epigenetics and Disease · doi:10.1007/978-3-7643-8989-5_1 · Cited by 165
Coding of neuronal differentiation by calcium transients
Spitzer, N. C., Lautermilch, N. J., Smith, R. D., & Gómez, T. M. (2000) · BioEssays · doi:10.1002/1521-1878(200009)22:9<811::aid-bies6>3.0.co;2-g · Cited by 164
Sirtuin 1 (SIRT1): The Misunderstood HDAC
Stünkel, W., & Campbell, R. M. (2011) · SLAS DISCOVERY · doi:10.1177/1087057111422103 · Cited by 164
Sauve, A. A. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2010.01.021 · Cited by 161
Zhou, Q., Atadja, P., & Davidson, N. E. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.1.3549 · Cited by 160
Selective Small Molecules Blocking HIV-1 Tat and Coactivator PCAF Association
Zeng, L., Li, J., Muller, M., Yan, S., Mujtaba, S., Pan, C., Wang, Z., & Zhou, M.-M. (2005) · Journal of the American Chemical Society · doi:10.1021/ja044885g · Cited by 160
Luo, X., Liu, Y., Kubicek, S., Myllyharju, J., Tumber, A., Ng, S. S., Che, K. H., Podoll, J. D., Heightman, T. D., Oppermann, U. C. T., et al. (2011) · Journal of the American Chemical Society · doi:10.1021/ja201597b · Cited by 155
Bertram, C. E., Khan, O., Ohri, S. K., Phillips, D. I. W., Matthews, S. G., & Hanson, M. A. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2007.147967 · Cited by 154
Culhane, J. C., Wang, D., Yen, P. M., & Cole, P. A. (2010) · Journal of the American Chemical Society · doi:10.1021/ja909996p · Cited by 154
Identification and Characterization of Propionylation at Histone H3 Lysine 23 in Mammalian Cells
Liu, B., Lin, Y.-H., Darwanto, A., Song, X., Xu, G., & Zhang, K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.045856 · Cited by 153
SIRT1 Genetic Variation Is Related to BMI and Risk of Obesity
Zillikens, M. C., van Meurs, J. B. J., Rivadeneira, F., Amin, N., Albert Hofman, D., Oostra, B. A., Sijbrands, E. J. G., Witteman, J. C. M., Pols, H. A. P., van Duijn, C. M., et al. (2009) · Diabetes · doi:10.2337/db09-0536 · Cited by 150
Histone acetyltransferases are crucial regulators in NF-κB mediated inflammation
Ghizzoni, M., Haisma, H. J., Maarsingh, H., & Dekker, F. J. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.03.009 · Cited by 149
Cardellini, M., Menghini, R., Martelli, E., Casagrande, V., Marino, A., Rizza, S., Porzio, O., Mauriello, A., Solini, A., Ippoliti, A., et al. (2009) · Diabetes · doi:10.2337/db09-0280 · Cited by 147
A Small Molecule Binding to the Coactivator CREB-Binding Protein Blocks Apoptosis in Cardiomyocytes
Borah, J. C., Mujtaba, S., Karakikes, I., Zeng, L., Müller, M., Patel, J. A., Moshkina, N., Morohashi, K., Zhang, W., Gerona‐Navarro, G., et al. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.12.021 · Cited by 145
Central Administration of Resveratrol Improves Diet-Induced Diabetes
Ramadori, G., Gautron, L., Fujikawa, T., Vianna, C. R., Elmquist, J. K., & Coppari, R. (2009) · Endocrinology · doi:10.1210/en.2009-0528 · Cited by 142
Novotny‐Diermayr, V., Sangthongpitag, K., Hu, C. Y., Wu, X., Sausgruber, N., Yeo, P., Greicius, G., Pettersson, S., Liang, A. L., Loh, Y. K., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0689 · Cited by 141
Adding a Lysine Mimic in the Design of Potent Inhibitors of Histone Lysine Methyltransferases
Chang, Y., Ganesh, T., Horton, J. R., Spannhoff, A., Liu, J., Sun, A., Zhang, X., Bedford, M. T., Shinkai, Y., Snyder, J. P., et al. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.04.048 · Cited by 126
Medda, F., Russell, R. J. M., Higgins, M., McCarthy, A. R., Campbell, J., Slawin, A. M. Z., Lane, D. P., Laín, S., & Westwood, N. J. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm8014298 · Cited by 124
Small-Molecule Ligands of Methyl-Lysine Binding Proteins
Herold, J. M., Wigle, T. J., Norris, J. L., Lam, R., Korboukh, V. K., Gao, C., Ingerman, L. A., Kireev, D., Senisterra, G. A., Vedadi, M., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200045v · Cited by 123
Self-citationDistribution Analysis of Deacetylase SIRT1 in Rodent and Human Nervous Systems
Zakhary, S. M., Ayubcha, D., Dileo, J. N., Jose, R., Leheste, J. R., Horowitz, J. M., & Torres, G. (2010) · The Anatomical Record · doi:10.1002/ar.21116 · Cited by 120
Furlan, A., Monzani, V., Reznikov, L. L., Leoni, F., Fossati, G., Modena, D., Mascagni, P., & Dinarello, C. A. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00020 · Cited by 120
Beier, U. H., Akimova, T., Liu, Y., Wang, L., & Hancock, W. W. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.07.002 · Cited by 118
Structural basis for CARM1 inhibition by indole and pyrazole inhibitors
Sack, J. S., Thieffine, S., Bandiera, T., Fasolini, M., Duke, G. J., Jayaraman, L., Kish, K., Klei, H. E., Purandare, A. V., Rosettani, P., et al. (2011) · Biochemical Journal · doi:10.1042/bj20102161 · Cited by 109
PR-domain–containing Mds1-Evi1 is critical for long-term hematopoietic stem cell function
Zhang, Y., Stehling-Sun, S., Lezon-Geyda, K., Juneja, S. C., Coillard, L., Chatterjee, G., Wuertzer, C. A., Camargo, F. D., & Perkins, A. S. (2011) · Blood · doi:10.1182/blood-2011-02-334680 · Cited by 108
van Essen, D., Zhu, Y., & Saccani, S. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.08.010 · Cited by 107
Genetic and epigenetic defects in mental retardation
Kramer, J. M., & van Bokhoven, H. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.08.009 · Cited by 103
Glycemic memory associated epigenetic changes
Siebel, A. L., Fernández, A. Z., & El‐Osta, A. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.06.005 · Cited by 102
Differential Histone Deacetylase mRNA Expression Patterns in Amyotrophic Lateral Sclerosis
Janssen, C., Schmalbach, S., Boeselt, S., Sarlette, A., Dengler, R., & Petri, S. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181ddd404 · Cited by 100
Loe-Mie, Y., Lepagnol-Bestel, A.-M., Maussion, G., Doron‐Faigenboim, A., Imbeaud, S., Delacroix, H., Aggerbeck, L. P., Pupko, T., Gorwood, P. A. P. M., Simonneau, M., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq184 · Cited by 97
Fine Tuning Our Cellular Factories: Sirtuins in Mitochondrial Biology
Zhong, L., & Mostoslavsky, R. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.05.004 · Cited by 94
Wang, H., Yu, N., Chen, D., Lee, K. C. L., Lye, P. L., Chang, J. W. W., Deng, W., Ng, M., Lu, T., Khoo, M. L., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2003552 · Cited by 94
Self-citationBlanco, D., Vicent, S., Fraga, M. F., Fernandez‐Garcia, I., Freire, J., Lujambio, A., Esteller, M., Ortíz-de-Solórzano, C., Pío, R., Lecanda, F., et al. (2007) · Neoplasia · doi:10.1593/neo.07517 · Cited by 92
Severinsen, J. E., Bjarkam, C. R., Kiar-Larsen, S., Olsen, I. M. L., Nielsen, M. M., Blechingberg, J., Nielsen, A. L., Holm, I. E., Foldager, L., Young, B. D., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001885 · Cited by 90
Mandl–Weber, S., Meinel, F. G., Jankowsky, R., Oduncu, F. S., Schmidmaier, R., & Baumann, P. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08124.x · Cited by 87
Catalytic Roles for Carbon-Oxygen Hydrogen Bonding in SET Domain Lysine Methyltransferases
Couture, J., Hauk, G., Thompson, M. J., Blackburn, G. M., & Trievel, R. C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602257200 · Cited by 83
Structural Chemistry of the Histone Methyltransferases Cofactor Binding Site
Campágna‐Slater, V., Mok, M. W., Nguyen, K. T., Fehér, M., Najmanovich, R., & Schapira, M. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci100479z · Cited by 82
Self-citationInhibition of Histone Demethylases by 4‐Carboxy‐2,2′‐Bipyridyl Compounds
Chang, K., King, O. N. F., Tumber, A., Woon, E. C. Y., Heightman, T. D., McDonough, M. A., Schofield, C. J., & Rose, N. R. (2011) · ChemMedChem · doi:10.1002/cmdc.201100026 · Cited by 82
Dowden, J., Hong, W., Parry, R. V., Pike, R. A., & Ward, S. G. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.02.069 · Cited by 72
Epigenetics: Unravelling the cancer code
Brower, V. (2011) · Nature · doi:10.1038/471s12a · Cited by 66
Lucas, D. M., Alinari, L., West, D. A., Davis, M. E., Edwards, R. B., Johnson, A. J., Blum, K. A., Hofmeister, C. C., Freitas, M. A., Parthun, M. R., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010941 · Cited by 60
Sirtuins and inflammation: Friends or foes?
Gallí, M., Gool, F. V., & Léo, O. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.12.010 · Cited by 56
Ogasawara, D., Suzuki, T., Mino, K., Ueda, R., Khan, M. N. A., Matsubara, T., Koseki, K., Hasegawa, M., Sasaki, R., Nakagawa, H., et al. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.12.024 · Cited by 52
Epigenetic opportunities and challenges in cancer
Best, J. D., & Carey, N. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.10.010 · Cited by 51
Trubia, M., Albano, F., Cavazzini, F., Cambrin, G. R., Quarta, G., Fabbiano, F., Ciambelli, F., Magro, D., Hernández‐Rivas, J. M., Mancini, M., et al. (2005) · Leukemia · doi:10.1038/sj.leu.2404020 · Cited by 42
Epigenetic therapies for non-oncology indications
Best, J. D., & Carey, N. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.10.006 · Cited by 37
Valle, N. R.-D., Gao, S., Miller, C. P., Fulbright, J. M., Gonzales, C., Sirisawad, M., Steggerda, S. M., Wheler, J. J., Balasubramanian, S., & Chandra, J. (2010) · International Journal of Cell Biology · doi:10.1155/2010/207420 · Cited by 36
Hwang, J. J., Kim, Y. S., Kim, T., Kim, M. J., Jeong, I. G., Lee, J., Choi, J., Jang, S.-J., Ro, S., & Kim, C. (2011) · Investigational New Drugs · doi:10.1007/s10637-011-9718-1 · Cited by 35
Structural Biology of Human Metal-Dependent Histone Deacetylases
Schapira, M. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-21631-2_10 · Cited by 32
Self-citationChemical biology of Histone acetyltransferase natural compounds modulators
Piaz, F. D., Vassallo, A., Cuesta‐Rubio, O., Castellano, S., Sbardella, G., & Tommasi, N. D. (2010) · Molecular Diversity · doi:10.1007/s11030-010-9299-5 · Cited by 32
The epigenetic basis of the Warburg effect
Wang, X., & Jin, H. (2010) · Epigenetics · doi:10.4161/epi.5.7.12662 · Cited by 27
Wisastra, R., Ghizzoni, M., Maarsingh, H., Minnaard, A. J., Haisma, H. J., & Dekker, F. J. (2011) · Organic & Biomolecular Chemistry · doi:10.1039/c0ob00464b · Cited by 26
Cox, M. V. (2013) · doi:10.4324/9780203775707-7 · Cited by 9
HDAC Inhibitors--CHI's Third Annual Conference.
Rosato, R. R. (2010) · PubMed · Cited by 1
Research works printed but not linked: 1
- Allis, C. D., Jenuwein, T. & Reinberg, D. Epigenetics (Cold Spring Harbor Laboratory Press, New York, 2007).
Cited by
The molecular hallmarks of epigenetic control
Allis, C. D., & Jenuwein, T. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.59 · Cited by 2,809
Targeting macrophages: therapeutic approaches in cancer
Cassetta, L., & Pollard, J. W. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.169 · Cited by 2,048
Pan-cancer patterns of somatic copy number alteration
Zack, T. I., Schumacher, S. E., Carter, S. L., Cherniack, A. D., Saksena, G., Tabak, B., Lawrence, M. S., Zhang, C.-Z., Wala, J., Mermel, C. H., et al. (2013) · Nature Genetics · doi:10.1038/ng.2760 · Cited by 1,870
Epigenetic Determinants of Cancer
Baylin, S. B., & Jones, P. A. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a019505 · Cited by 1,226
“The clinical successes with current epigenetic drugs have led to a big increase in interest from the pharmaceutical industry in developing compounds that will target epigenetic abnormalities in cancers (Kelly et al. 2010; Dawson et al. 2011; Arrowsmith et al. 2012).”
BackgroundSmall molecules, big targets: drug discovery faces the protein–protein interaction challenge
Scott, D. E., Bayly, A. R., Abell, C., & Skidmore, J. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.29 · Cited by 1,137
Metadata
- Authors
- Arrowsmith, C. H., Bountra, C., Fish, P. V., Lee, K., & Schapira, M.
- Affiliations
- University of Toronto (CA)
- University of Oxford (GB)
- GlaxoSmithKline (United Kingdom) (GB)
- Corresponding author
- Arrowsmith, Cheryl H.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2012-04-13
- Volume
- 11
- Issue
- 5
- Pages
- 384-400
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2076333986
- Semantic Scholar
- fd3346db3efdf967ef263b7d902523d5edecb53e
- Cited by
- 1,327
- References
- 194
- Citations by year
- 2026: 29 · 2025: 49 · 2024: 47 · 2023: 47 · 2022: 62 · 2021: 85 · 2020: 103 · 2019: 103 · 2018: 93 · 2017: 126 · 2016: 165 · 2015: 132 · 2014: 115 · 2013: 116 · 2012: 54
- FWCI
- 12.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Eli Lilly and Company
- Pfizer
- Genome Canada
- Wellcome Trust (1097737)
- Ontario Genomics
- Ontario Genomics Institute
- Canadian Institutes of Health Research (1097737)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- epigenetic regulation, histone acetylation, histone methylation, histone deacetylase, protein methyltransferases, lysine demethylase, bromodomain proteins, epigenetic drug targets, epigenetic drug discovery, cancer, inflammation, neuropsychiatric disorders
- MeSH terms
- Acetylation, Animals, Gene Expression Regulation, Histones, Humans, Methylation, Protein Binding, Proteins, Signal Transduction, Epigenesis, Genetic, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.